IONS
IONIS PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$44.44
−4.94%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 211.76x
- P/S forward
- 7.90x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.79x
- Price / sales
- 8.45x
- Price / cash flow
- -14.88x
Enterprise value
- Enterprise value
- $7.7B
- EV / sales
- 8.87x
- EV / EBITDA
- 1.79x
- EV / EBIT
- -13.03x
- Market cap
- $7.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026